(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.35%) $91.45
Live Chart Being Loaded With Signals
Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products...
Stats | |
---|---|
Dagens volum | 1.86M |
Gjennomsnittsvolum | 1.04M |
Markedsverdi | 178.87M |
EPS | £0 ( 2024-04-09 ) |
Last Dividend | £1.184 ( 2023-06-22 ) |
Next Dividend | £0 ( N/A ) |
P/E | -33.10 |
ATR14 | £0.114 (0.34%) |
Volum Korrelasjon
Alliance Pharma PLC Korrelasjon
10 Mest positive korrelasjoner | |
---|---|
RCN.L | 0.919 |
XUEB.L | 0.905 |
BIRG.L | 0.905 |
AIBG.L | 0.902 |
FOG.L | 0.896 |
EBQ.L | 0.885 |
NUM.L | 0.883 |
DTY.L | 0.881 |
EMAU.L | 0.871 |
CLIN.L | 0.867 |
10 Mest negative korrelasjoner | |
---|---|
TEP.L | -0.906 |
3NIS.L | -0.896 |
LNGA.L | -0.885 |
GFIN.L | -0.884 |
INHC.L | -0.882 |
PTRO.L | -0.882 |
GIF.L | -0.882 |
BIDS.L | -0.878 |
ECHO.L | -0.872 |
PUR.L | -0.871 |
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Alliance Pharma PLC Korrelasjon - Valuta/Råvare
Alliance Pharma PLC Økonomi
Annual | 2022 |
Omsetning: | £167.42M |
Bruttogevinst: | £101.68M (60.74 %) |
EPS: | £0.00170 |
FY | 2022 |
Omsetning: | £167.42M |
Bruttogevinst: | £101.68M (60.74 %) |
EPS: | £0.00170 |
FY | 2021 |
Omsetning: | £163.21M |
Bruttogevinst: | £109.45M (67.06 %) |
EPS: | £0.0137 |
FY | 2020 |
Omsetning: | £129.80M |
Bruttogevinst: | £82.82M (63.80 %) |
EPS: | £0.0154 |
Financial Reports:
No articles found.
Alliance Pharma PLC Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
£0 (N/A) |
£0.592 (N/A) |
£0 (N/A) |
£1.184 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | £0.0700 | 2009-12-02 |
Last Dividend | £1.184 | 2023-06-22 |
Next Dividend | £0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 28 | -- |
Total Paid Out | £15.63 | -- |
Avg. Dividend % Per Year | 1.27% | -- |
Score | 3 | -- |
Div. Sustainability Score | 6.61 | |
Div.Growth Potential Score | 1.442 | |
Div. Directional Score | 4.03 | -- |
Year | Amount | Yield |
---|---|---|
2009 | £0.0700 | 2.33% |
2010 | £0.400 | 1.48% |
2011 | £0.650 | 2.11% |
2012 | £0.775 | 2.51% |
2013 | £0.853 | 2.67% |
2014 | £0.938 | 2.32% |
2015 | £1.033 | 2.79% |
2016 | £1.137 | 2.65% |
2017 | £1.250 | 2.75% |
2018 | £1.375 | 2.04% |
2019 | £1.513 | 2.30% |
2020 | £0.536 | 0.63% |
2021 | £2.20 | 2.50% |
2022 | £1.720 | 1.57% |
2023 | £1.184 | 2.17% |
2024 | £0 | 0.00% |
With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
VLX.L | Dividend Knight | 2023-07-20 | Sporadic | 32 | 0.82% | |
MRCH.L | Dividend King | 2023-07-06 | Quarterly | 53 | 3.07% | |
DIVI.L | Dividend Knight | 2023-09-28 | Quarterly | 14 | 1.99% | |
SHOE.L | Dividend Knight | 2023-07-13 | Annually | 10 | 2.57% | |
IHG.L | Dividend Knight | 2023-08-31 | Annually | 21 | 1.16% | |
BMY.L | Dividend Knight | 2023-07-27 | Annually | 30 | 1.76% | |
OCN.L | Dividend Knight | 2023-05-18 | Annually | 19 | 3.96% | |
EPWN.L | Dividend Knight | 2023-09-28 | Annually | 11 | 2.16% | |
STM.L | Dividend Knight | 2023-08-31 | Semi-Annually | 17 | 2.49% | |
JLEN.L | Dividend King | 2023-08-31 | Quarterly | 11 | 366.93% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.0415 | 1.500 | -0.830 | -1.245 | [0 - 0.5] |
returnOnAssetsTTM | -0.0137 | 1.200 | -0.458 | -0.550 | [0 - 0.3] |
returnOnEquityTTM | -0.0250 | 1.500 | -1.389 | -2.08 | [0.1 - 1] |
payoutRatioTTM | -1.315 | -1.000 | -10.00 | 10.00 | [0 - 1] |
currentRatioTTM | 1.931 | 0.800 | 5.35 | 4.28 | [1 - 3] |
quickRatioTTM | 1.333 | 0.800 | 6.86 | 5.49 | [0.8 - 2.5] |
cashRatioTTM | 0.533 | 1.500 | 8.15 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.242 | -1.500 | 5.96 | -8.94 | [0 - 0.6] |
interestCoverageTTM | 3.05 | 1.000 | 9.98 | 9.98 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.0402 | 2.00 | 9.99 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.0397 | 2.00 | 9.98 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.449 | -1.500 | 8.20 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.516 | 1.000 | 4.74 | 4.74 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.144 | 1.000 | 9.13 | 9.13 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.174 | 1.000 | -0.143 | -0.143 | [0.2 - 2] |
assetTurnoverTTM | 0.331 | 0.800 | -1.127 | -0.901 | [0.5 - 2] |
Total Score | 6.61 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -25.32 | 1.000 | -2.66 | 0 | [1 - 100] |
returnOnEquityTTM | -0.0250 | 2.50 | -0.893 | -2.08 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.0397 | 2.00 | 9.99 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 3.58 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.0402 | 2.00 | 9.99 | 10.00 | [0 - 30] |
payoutRatioTTM | -1.315 | 1.500 | -10.00 | 10.00 | [0 - 1] |
pegRatioTTM | -47.87 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.128 | 1.000 | 9.31 | 0 | [0.1 - 0.5] |
Total Score | 1.442 |
Alliance Pharma PLC
Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. It holds the marketing rights of approximately 80 consumer healthcare and prescription medicine products. The company also offers medical devices, food supplements, and cosmetics. Alliance Pharma plc provides its products under the Aloclair, Anbesol, Asthon and Parsons, Atopiclair, Forceval, Hydromol, Kelo-cote, Macushield, Vamousse, Nizoral, and Amberen brand names. The company was founded in 1996 and is headquartered in Chippenham, the United Kingdom.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.